Clinical Trial Update: Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pre-treatment with a GLP-1 analog (liraglutide) in patients awaiting bariatric surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Obesity | Phase 3 | Status: TERMINATED